Literature DB >> 27379853

[Practical Aspects of Sclerotherapy].

Markus Stücker1, Martin Dörler2.   

Abstract

Sclerotherapy is an important part of the treatment of varicose veins. It may also be performed in patients with contraindications for operative procedures. By adjusting the mode of application (liquid or foam) and the concentration it can be used for the treatment of all vein types. In comparison to other treatment options it is especially well suited for the treatment of spider veins and reticular veins, pudendal varicosity and so called "feeding" varicose veins in the proximity of venous leg ulcers. A current European guideline, which was approved by 23 European phlebologic societies, supports the good international standardization of this treatment technique.

Entities:  

Keywords:  Polidocanol; Sclerotherapy; Spider veins; Varicose vein

Mesh:

Substances:

Year:  2016        PMID: 27379853     DOI: 10.1007/s10354-016-0483-9

Source DB:  PubMed          Journal:  Wien Med Wochenschr        ISSN: 0043-5341


  7 in total

1.  Migraine ophthalmique with reversible scotomas after sclerotherapy with liquid 1% polidocanol.

Authors:  Beate Künzlberger; Carsten Pieck; Peter Altmeyer; Markus Stücker
Journal:  Dermatol Surg       Date:  2006-11       Impact factor: 3.398

2.  Air contamination in the sclerosing foam for the treatment of varicose veins.

Authors:  S de Franciscis; Cga Nobile; E Larosa; R Montemurro; R Serra
Journal:  Phlebology       Date:  2014-12-15       Impact factor: 1.740

Review 3.  Results from RCTs in Sclerotherapy: European Guidelines for Sclerotherapy in Chronic Venous Disorders*

Authors:  F Pannier; E Rabe
Journal:  Phlebology       Date:  2014-05-19       Impact factor: 1.740

Review 4.  Endovenous chemical (and physical) treatments for varices: what's new?

Authors:  Jean-Jérôme Guex
Journal:  Phlebology       Date:  2014-05-19       Impact factor: 1.740

5.  Subcutaneous injection of liquid and foamed polidocanol: extravasation is not responsible for skin necrosis during reticular and spider vein sclerotherapy.

Authors:  S Schuller-Petrović; M D Pavlović; N Neuhold; F Brunner; G Wölkart
Journal:  J Eur Acad Dermatol Venereol       Date:  2010-10-15       Impact factor: 6.166

6.  Safety and efficiency of perilesional sclerotherapy in leg ulcer patients with postthrombotic syndrome and/or oral anticoagulation with phenprocoumon.

Authors:  Markus Stücker; Stefanie Reich; Nico Hermes; Peter Altmeyer
Journal:  J Dtsch Dermatol Ges       Date:  2006-09       Impact factor: 5.584

7.  Catheter-directed foam sclerotherapy of great saphenous veins in combination with pre-treatment reduction of the diameter employing the principals of perivenous tumescent local anesthesia.

Authors:  N Devereux; A L Recke; L Westermann; A Recke; B Kahle
Journal:  Eur J Vasc Endovasc Surg       Date:  2013-10-30       Impact factor: 7.069

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.